• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Seed Junky Genetics Announces MINNTZ Return

LOS ANGELES – JBeezy, the founder of Seed Junky Genetics, confirmed that the MINNTZ® brand is officially returning as an independent line following a new agreement with Michigan-based HNG Solutions, LLC. The partnership will put ...

Trump Fast Tracks Psychedelic Research

WASHINGTON D.C- President Donald Trump has signed a sweeping executive order to accelerate psychedelic research and expand patient access across the United States—marking one of the most significant federal policy shifts the sector has seen ...

BLAZE Launches Herbie AI Budtender for Cannabis E-Commerce

ANAHEIM – BLAZE, an AI-powered retail technology suite specifically designed for Cannabis dispensaries, delivery services, payments, and e-commerce has introduced Herbie AI Budtender – the virtual assistant providing personalized product guidance to customers shopping online. ...

Curaleaf Extends Automatic Share Disposition Plan

STAMFORD – Curaleaf Holdings Inc. disclosed that Peter Clateman, its Chief Legal Officer, has extended an existing automatic securities disposition plan (ASDP) to handle the exercise of stock options due to expire in July 2027 ...

Cannara Biotech Reports Q2 2026 Financial Results

MONTREAL – Cannara Biotech Inc. posted its fiscal second-quarter results, recording higher revenues and a sharp improvement in cash generation as the Quebec-based producer continued to pick up ground in a flat national Cannabis market. ...

High-Potency Cannabis Strains Impact Legal and Health Systems

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

MJ and MSOS ETFs Signal High Upside on U.S. Legalization Outlook

LOS ANGELES- Investment in cannabis-focused ETFs such as Amplify’s MJ and AdvisorShares’ MSOS reflects growing investor anticipation of federal legalization-driven expansion, even amid pronounced volatility and structural headwinds. Analysts argue that rescheduling cannabis from Schedule I ...

Canadian Cannabis Producers Expand Exports

LOS ANGELES- Canada’s licensed cannabis sector continues its move toward international markets, driven by strong global demand, especially for medical cannabis. During the 2023–24 fiscal year, Canada exported approximately CA$218 million of medical cannabis for commercial ...

Emerging Programs Aim to Democratize Cannabis Cultivation

LOS ANGELES- Governments, industry groups, and educational institutions are launching a wave of initiatives aimed at lowering barriers to entry in cannabis cultivation and production—efforts collectively referred to as “democratizing cannabis production.” These programs focus ...

Subscribe To Our Newsletter

Go to Top